Want to see CALC full AI Analyst Report?
CalciMedica (CALC) Ratios
CalciMedica Ratios
CALC's free cash flow for Q2 2026 was $-4.62M. For the 2026 fiscal year, CALC's free cash flow was increased by $0.00 and operating cash flow was $-4.62M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.58 | 5.34 | 2.88 | 0.36 | 16.53 |
| Quick Ratio | 3.58 | 5.34 | 2.88 | 0.36 | 16.54 |
| Cash Ratio | 3.05 | 2.15 | 1.37 | 0.28 | 3.29 |
| Solvency Ratio | -1.46 | -2.53 | -8.52 | -0.62 | -8.68 |
| Operating Cash Flow Ratio | -5.60 | -5.74 | -6.39 | -2.46 | -7.76 |
| Short-Term Operating Cash Flow Coverage | -16.94 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -6.70M | $ 14.28M | $ 7.58M | $ -10.85M | $ 63.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.71 | 0.00 | 0.00 | 1.60 | 0.00 |
| Debt-to-Equity Ratio | -1.46 | 0.00 | 0.00 | -0.58 | 0.00 |
| Debt-to-Capital Ratio | 3.17 | 0.00 | 0.00 | -1.38 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 4.67 | 0.00 | 0.00 | -1.27 | 0.00 |
| Financial Leverage Ratio | -2.05 | 1.37 | 1.49 | -0.36 | 1.06 |
| Debt Service Coverage Ratio | -10.51 | 0.00 | -345.61 | -57.88 | -280.17 |
| Interest Coverage Ratio | -16.26 | 0.00 | -346.14 | -107.52 | -285.29 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.58 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.02 | 3.58 | 0.08 |
| Net Debt to EBITDA | 0.06 | 0.58 | 0.15 | -0.53 | 0.38 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 127.86% | 56.60% | 90.24% | 55.13% | 99.65% |
| Return on Assets (ROA) | -217.51% | -69.21% | -281.96% | -233.62% | -51.85% |
| Return on Equity (ROE) | 445.14% | -95.07% | -421.20% | 84.74% | -55.09% |
| Return on Capital Employed (ROCE) | -235.71% | -150.24% | -466.78% | 991.82% | -55.28% |
| Return on Invested Capital (ROIC) | -209.07% | -150.24% | -466.78% | 1155.78% | -55.28% |
| Return on Tangible Assets | -217.51% | -69.21% | -281.96% | -233.62% | -51.85% |
| Earnings Yield | -0.03% | -34.41% | -267.55% | -87.28% | -405.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.04 | 0.00 | 0.00 | 0.00 | 0.98 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | -24.71 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -9212.28 | 0.00 | 0.00 | 0.00 | -385.39 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | -14.77 |
| Days of Payables Outstanding | 9212.28 | 0.00 | 0.00 | 0.00 | 370.63 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | -14.77 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -1.88 | -5.73 | -7.66 | -20.80 |
| Free Cash Flow Per Share | -0.01 | -1.88 | -5.75 | -7.66 | -21.12 |
| Dividend Paid and CapEx Coverage Ratio | -756.36 | -2643.25 | -329.87 | -2939.25 | -64.55 |
| Capital Expenditure Coverage Ratio | -756.36 | -2643.25 | -329.87 | -2939.25 | -64.55 |
| Operating Cash Flow Coverage Ratio | -2.18 | 0.00 | 0.00 | -2.19 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -0.02% | -53.14% | -200.97% | -131.20% | -361.73% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.35 | -2.91 | -0.37 | -1.15 | -0.25 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -14896.04 | 2.76 | 1.57 | -0.97 | 0.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4664.93 | -1.88 | -0.50 | -0.76 | -0.28 |
| Price-to-Operating Cash Flow Ratio | -4671.10 | -1.88 | -0.50 | -0.76 | -0.28 |
| Price-to-Earnings Growth (PEG) Ratio | -0.05 | 0.03 | 0.01 | 0.59 | 0.00 |
| Enterprise Value Multiple | -3521.14 | -2.34 | -0.19 | -1.70 | 0.13 |
| Enterprise Value | 98.92B | 31.88M | 7.31M | 13.00M | -4.52M |
| EV to EBITDA | -3521.14 | -2.34 | -0.19 | -1.70 | 0.13 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -4664.85 | -1.51 | -0.28 | -1.11 | 0.14 |
| EV to Operating Cash Flow | -4671.02 | -1.51 | -0.28 | -1.11 | 0.14 |
| Tangible Book Value Per Share | -0.00 | 1.28 | 1.82 | -6.02 | 42.94 |
| Shareholders’ Equity Per Share | -0.00 | 1.28 | 1.82 | -6.02 | 42.94 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -1.22 | -7.65 | -5.10 | -23.66 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.05 | 1.00 | 0.90 | 1.02 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.72 | 1.54 | 0.75 | 1.50 | 0.88 |
Currency in USD